Fennec Pharmaceuticals Inc. Revenue 2011–2025
Fennec Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Fennec Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 15.1 M, a 72.64% increase year-over-year.
- Fennec Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 46.0 M, a 0.34% decrease year-over-year.
- Fennec Pharmaceuticals Inc. annual revenue for 2025 was 44.6 M, a 6.09% decrease from 2024.
- Fennec Pharmaceuticals Inc. annual revenue for 2024 was 47.5 M, a 123.69% increase from 2023.
- Fennec Pharmaceuticals Inc. annual revenue for 2023 was 21.3 M, a 1284.50% increase from 2022.
- Fennec Pharmaceuticals Inc. annual revenue for 2022 was 1.5 M.
Fennec Pharmaceuticals Inc. (FENC) — Frequently Asked Questions
Fennec Pharmaceuticals Inc. (FENC) is a publicly traded US company. It has a market capitalization of $249M. In fiscal 2025 it reported revenue of $45M and net income of -$10M. Explore FENC's stock price, financial statements, earnings history, margins and key ratios below.
What is Fennec Pharmaceuticals Inc.'s market cap?
Fennec Pharmaceuticals Inc. (FENC) has a market capitalization of $249M.
What is the FENC stock price?
FENC trades at $8.70 (-0.80% on the day).
How much revenue does Fennec Pharmaceuticals Inc. make?
Fennec Pharmaceuticals Inc. reported revenue of $45M in fiscal 2025.
Is FENC profitable?
In fiscal 2025, Fennec Pharmaceuticals Inc. reported net income of -$10M.